MOLECULAR DOCKING, ADMET, SYNTHESIS, AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF NEW ETODOLAC DERIVATIVES CONTAINING PYRAZOLINE MOIETY

Authors

  • HASSAN F. ABED Ministry of Health, Al-Qadisiya, Iraq
  • TAGREED N-A OMAR Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i11.56550

Keywords:

Molecular Docking, Anti-inflammatory, Antimicrobial activity, Etodolac hydrazide, Pyrazoline

Abstract

Objective: The main objectives were to use molecular docking to create compounds with antibacterial activity and anti-inflammatory properties that are still effective. For future application, these compounds must also have acceptable absorption, distribution, metabolism, excretion, and possible toxicity (ADMET) characteristics.

Methods: Ligand Designer using Glide (Schrodinger LLC) molecular docking studies. A new etodolac derivative containing a pyrazoline ring was synthesized and characterized using ATR-FTIR and 1H-NMR. Furthermore, their pharmacological activities were investigated. In order to determine the derivatives’ pharmacological characteristics, we used a rat model for anti-inflammatory activity called rat egg white-induced paw edema. The agar-well diffusion method was used to assess the in vitro antimicrobial activity of the test substances against a variety of microorganisms.

Results: The newly synthesized compounds HF7 and HF9, as shown in the molecular docking study findings with the cyclooxygenase-2 protein (PDB code: 4m11), exhibit binding energies of −9.247 and −8.716, respectively, which are greater than the reference docking result. During docking analysis using the Saccharomyces cerevisiae CYP51 receptor (PDB code: 4wmz), all synthesized compounds demonstrated higher docking scores compared to fluconazole, which served as the reference standard. The rat paw edema technique showed considerable action of HF6 and HF8 have a stronger impact compared to the standard impact. According to antimicrobial research results, HF8’s (minimum inhibitory concentration [MIC]) against Staphylococcus aureus and Streptococcus pyogenes is 64 mcg/mL, whereas derivatives HF7 and HF11 also demonstrated MIC of 64 mcg/mL against S. aureus.

Conclusion: The effective synthesis of a new class of pyrazoline compounds was achieved. Most of the recently identified pyrazoline compounds were more effective against the microorganisms under investigation, with compounds HF7, HF8, and HF11 showing the greatest effectiveness in comparison to the standards used (fluconazole and amoxicillin).

Downloads

Download data is not yet available.

References

1. Ma Y, Frutos-Beltrán E, Kang D, Pannecouque C, De Clercq E, Menéndez-Arias L, et al. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem Soc Rev. 2021;50(7):4514-40. doi: 10.1039/d0cs01084g, PMID 33595031

2. Blanco-González A, Cabezón A, Seco-González A, Conde-Torres D, Antelo-Riveiro P, Piñeiro Á, et al. The role of AI in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals (Basel). 2023;16(6):891. doi: 10.3390/ph16060891, PMID 37375838

3. Ballante F, Kooistra AJ, Kampen S, De Graaf C, Carlsson J. Structure-based virtual screening for ligands of G protein-coupled receptors: What can molecular docking do for you? Pharmacol Rev. 2021;73(4):527-65. doi: 10.1124/pharmrev.120.000246, PMID 34907092

4. Salah S, Mahmoud AA, Kamel AO. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: Ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv. 2017;24(1):846-56. doi: 10.1080/10717544.2017.1326539, PMID 28535740

5. Tziona P, Theodosis-Nobelos P, Papagiouvannis G, Petrou A, Drouza C, Rekka EA. Enhancement of the anti-inflammatory activity of NSAIDs by their conjugation with 3,4,5-trimethoxybenzyl alcohol. Molecules. 2022;27(7):2104. doi: 10.3390/molecules27072104, PMID 35408503

6. Ahmadi M, Bekeschus S, Weltmann KD, Von Woedtke T, Wende K. Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors. RSC Med Chem. 2022;13(5):471-96. doi: 10.1039/d1md00280e, PMID 35685617

7. Hamdoon YS, Hadi MK. Molecular docking, ADMET, synthesis and evaluation of new indomethacin hydrazide derivatives as antibacterial agents. Pharmacia. 2024;71:1-10. doi: 10.3897/pharmacia.71.e127784

8. Shaik A, Rao AT, Venkatarao DV, Rao SV, Kishore PV. Novel etodolac-based 1,2,4-triazole derivatives as antimicrobial agents: Synthesis, biological evaluation, and molecular docking study. Russ J Org Chem. 2020;56(12):2179-87. doi: 10.1134/s1070428020120210

9. Rabee NW, Tagreed NA. Molecular docking, ADMET study, synthesis, anti-inflammatory, and antimicrobial screening of new NSAIDs conjugated with gabapentin. Iraqi J Pharm Sci. 2025;33((4SI)):362-82. doi: 10.31351/vol33iss(4si)pp362-382

10. Mervat Mohammed K, Tagreed NA. Synthesis, characterization, anti-inflammatory, and antimicrobial evaluation of new 2-pyrazolines derivatives derived from guaiacol. Iraqi J Pharm Sci. 2023;32 Suppl:254-61. doi: 10.31351/vol32isssuppl.pp254-261

11. Singh G, Goyal A, Bhatti RS, Arora S. Pyrazoline as a medicinal scaffold. Rev Bionatura. 2019;4(4):994-9. doi: 10.21931/rb/2019.04.04.10

12. Poorni KE, Gohulavani G, Muralidharan VP. Synthesis, characterization, antimicrobial and antioxidant activities of substituted pyrazolines from 2-acetylfluorene based chalcone. Int J Appl Pharm. 2022;14:111-5. doi: 10.22159/ijap.2022.v14ti.17

13. Cherfi M, Harit T, Amanchar M, Oulous A, Malek F. An overview of pyrazole-tetrazole-based hybrid compounds: Synthesis methods, biological activities and energetic properties. Organics. 2024;5(4): 575-97. doi: 10.3390/org5040030

14. Jain SK, Singhal R. A review on pyrazoline derivatives as antimicrobial agent. Int J Pharm Pharm Sci. 2020;12(6):15-24. doi: 10.22159/ ijpps.2020v12i6.37456

15. Shaymaa Kanaan K, Omar TN. Synthesis and preliminary anti-inflammatory and anti-microbial evaluation of new 4,5-dihydro- 1H-pyrazole derivatives. Iraqi J Pharm Sci. 2023;32 Suppl:262-70. doi: 10.31351/vol32isssuppl.pp262-270

16. Lominoga ER, Zadorozhnii PV, Kobets VV, Kiselev VV, Kharchenko AV. Synthesis, spectral characteristics, and molecular docking studies of 2-(2,4-dichlorophenoxy)-N-(2,2,2-trichloro-1-(3-arylthioureido)ethyl) acetamide. Eng Proc. 2023;56(1):195. doi: 10.3390/asec2023-15324

17. Sharma D, Kumar S, Narasimhan B, Ramasamy K, Lim SM, Shah SA, et al. 4-(4-bromophenyl)-thiazol-2-amine derivatives: Synthesis, biological activity and molecular docking study with ADME profile. BMC Chem. 2019;13(1):60. doi: 10.1186/s13065-019-0575-x, PMID 31384808

18. Ali RH, Al-Hamashi AA. Design, synthesis, and preliminary antiproliferative evaluation of 1,2,4-thiadiazole derivatives as possible histone deacetylase inhibitors. Iraqi J Pharm Sci. 2025;33((4SI)):57-66. doi: 10.31351/vol33iss(4SI)pp57-66

19. Mohammed M, Amjed Adnan A. In-silico design, molecular docking, molecular dynamic simulations, molecular mechanics with generalised born and surface area solvation study, and pharmacokinetic prediction of novel diclofenac as anti-inflammatory compounds. Turk Comp Theor Chem. 2024;8(3):108-21. doi: 10.33435/tcandtc.1355772

20. Maurya AK, Mishra N. In silico validation of coumarin derivatives as potential inhibitors against Main protease, NSP10/ NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2. J Biomol Struct Dyn. 2021;39(18):7306-21. doi: 10.1080/07391102.2020.1808075, PMID 32835632

21. Shridhar Deshpande N, Mahendra GS, Aggarwal NN, Gatphoh BF, Revanasiddappa BC. Insilico design, ADMET screening, MM-GBSA binding free energy of novel 1,3,4 oxadiazoles linked Schiff bases as PARP-1 inhibitors targeting breast cancer. Future J Pharm Sci. 2021;7(1):174. doi: 10.1186/s43094-021-00321-4

22. Hamad AA, Omer RA, Kaka KN, Amin AA, Ahmed KM, Rashid RF, et al. A review: New synthesis of chalcone derivatives and their applications. Chem Rev Lett. 2025;8:329-51. doi: 10.22034/ crl.2025.480229.1427

23. Al-Nakeeb MR, Omar TN. Synthesis, characterization and preliminary study of the anti-inflammatory activity of new pyrazoline containing ibuprofen derivatives. Iraqi J Pharm Sci. 2019;28(1):131-7. doi: 10.31351/vol28iss1pp131-137

24. Hassan OM, Sarsam SW. Synthesis, characterization and preliminary anti-inflammatory evaluation of new etodolac derivatives. Iraqi J Pharm Sci. 2019;28(1):106-12. doi: 10.31351/vol28iss1pp106-112

25. Hadi MK, Abdulkadir MQ, Abdul-Wahab A. Synthesis and antimicrobial evaluation of sulfonylhydrazide derivatives of etodolac. Int J Drug Deliv Technol. 2021;11(3):1000-3. doi: 10.25258/ijddt.11.3.59

26. Mahdi MF, Raauf AM, Mohammed NM. Synthesis, characterization and preliminary pharmacological evaluation of new non-steroidal anti-inflammatory pyrazoline derivatives. Eur J Chem. 2015;6(4):461-7. doi: 10.5155/eurjchem.6.4.461-467.1321

27. Mahdi GA, Dakhel ZA. Synthesis, characterization, and initial pharmacological assessment of new naproxen with 1,3,4-thiadiazol- 2-amine derivatives. Gomal J Med Sci. 2024;22(3):252-61. doi: 10.46903/gjms/22.03.1675

28. Abdulhamza HM, Farhan MS. Synthesis, characterization and preliminary anti-inflammatory evaluation of new fenoprofen hydrazone derivatives. Iraqi J Pharm Sci. 2020;29(2):239-44. doi: 10.31351/ vol29iss2pp239-244

29. Castro-Alvarez A, Costa AM, Vilarrasa J. The performance of several docking programs at reproducing protein-macrolide-like crystal structures. Molecules. 2017;22(1):136. doi: 10.3390/ molecules22010136, PMID 28106755

30. Mawla MC, Omar TN. In-silico molecular docking studies, synthesis and preliminary pharmacological evaluation of new pyrazoline derivatives bearing pyridine ring scaffolds. Int J Appl Pharm. 2025;17(4):309-25. doi: 10.22159/ijap.2025v17i4.54404

31. Yadav CS, Azad I, Khan AR, Nasibullah M, Ahmad N, Hansda D, et al. Recent advances in the synthesis of pyrazoline derivatives from chalcones as potent pharmacological agents: A comprehensive review. Results Chem. 2024;7:101326. doi: 10.1016/j.rechem.2024.101326

32. Orján EM, Kormányos ES, Fűr GM, Dombi Á, Bálint ER, Balla Z, et al. The anti-inflammatory effect of dimethyl trisulfide in experimental acute pancreatitis. Sci Rep. 2023;13(1):16813. doi: 10.1038/s41598- 023-43692-9, PMID 37798377

33. Huang J, Chen R, Zhou J, Zhang Q, Xue C, Li Y, et al. Comparative pharmacokinetic study of the five anti-inflammatory active ingredients of Inula cappa in a normal and an LPS-induced inflammatory cell model. Front Pharmacol. 2022;13:981112. doi: 10.3389/fphar.2022.981112, PMID 36199688

34. Mohammed ZB, Omar TN. Chemical design, synthesis and biological evaluoation of mutual prodrug of gabapentin with different types of phenolic and alcoholic antioxidants. Syst Rev Pharm. 2021;12(1): 858-68.

35. Sahib HA, Mohammed MH. Synthesis and preliminary biological activity evaluation of new N-substituted phthalimide derivatives. Iraqi J Pharm Sci. 2020;29(1):247-52. doi: 10.31351/vol29iss1pp247-252

Published

07-11-2025

How to Cite

HASSAN F. ABED, and TAGREED N-A OMAR. “MOLECULAR DOCKING, ADMET, SYNTHESIS, AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF NEW ETODOLAC DERIVATIVES CONTAINING PYRAZOLINE MOIETY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 11, Nov. 2025, pp. 215-26, doi:10.22159/ajpcr.2025v18i11.56550.

Issue

Section

Original Article(s)